Market Cap 8.76B
Revenue (ttm) 12.67B
Net Income (ttm) 390.00M
EPS (ttm) N/A
PE Ratio 15.03
Forward PE 14.80
Profit Margin 3.08%
Debt to Equity Ratio 0.51
Volume 3,332,800
Avg Vol 1,546,164
Day's Range N/A - N/A
Shares Out 121.72M
Stochastic %K 71%
Beta 0.86
Analysts Sell
Price Target $76.54

Company Profile

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PP...

Industry: Medical Distribution
Sector: Healthcare
Phone: 631 843 5500
Address:
135 Duryea Road, Melville, United States
swingingtech
swingingtech Jun. 4 at 9:53 PM
$CIEN $HSIC $RNA https://wallstreetwaves.com/key-wednesday-options-activity-cien-hsic-rna/
0 · Reply
OptionRunners
OptionRunners Jun. 4 at 6:27 PM
$HSIC Seller of the July 18th $75/$80 call spreads 5,000 times for $0.86. Looks to be closing those out for a loss.
0 · Reply
ZacksResearch
ZacksResearch May. 26 at 1:22 PM
Henry Schein ($HSIC) — is the stock a hidden gem or stuck in the mud? 🤔 📊 Henry Schein One's software is driving robust gains amid macroeconomic challenges, with nearly 20% YoY growth in Dentrix Ascend and Dentally subscriptions. 📉 Yet, global macro pressures and fierce competition could weigh on results, although the recent dip in gross profit was due to an increase in cost of sales. Deep dive here 👉 https://www.zacks.com/commentary/2477016/should-you-retain-henry-schein-stock-in-your-portfolio-right-now?cid=sm-stocktwits-2-2477016-body&ADID=SYND_STOCKTWITS_TWEET_2_2477016_BODY
0 · Reply
ZacksResearch
ZacksResearch May. 26 at 12:04 PM
Investors are optimistic about $HSIC, owing to the strong performance of its Henry Schein One business. Explore further: https://www.zacks.com/stock/news/2477016/should-you-retain-henry-schein-stock-in-your-portfolio-right-now?cid=sm-stocktwits-2-2477016-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2477016_TEASER
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine May. 16 at 8:08 PM
$HSIC closes $250M strategic investment from KKR - now holding 12% of shares. KKR's Dan Daniel joins board as independent director. Cash infusion helps debt concerns, but dilution at $76.10/share raises eyebrows. Market will decide if KKR's operational expertise justifies the equity cost. https://www.sec.gov/Archives/edgar/data/1000228/000119312525121679/d919434d8k.htm
0 · Reply
OptionRunners
OptionRunners May. 12 at 7:16 PM
$HSIC Buyer of the July 18th $75/$80 call spreads 5,000 times for $1.00
0 · Reply
JarvisFlow
JarvisFlow May. 6 at 1:29 PM
Wells Fargo has adjusted their stance on Henry Schein ( $HSIC ), setting the rating to Equal-Weight with a target price of 80 → 75.
0 · Reply
JarvisFlow
JarvisFlow May. 6 at 12:30 PM
Barrington Research updates rating for Henry Schein ( $HSIC ) to Outperform, target set at 90 → 86.
0 · Reply
DonCorleone77
DonCorleone77 May. 5 at 10:32 AM
$HSIC Henry Schein sees annual run-rate savings at high end of $75M-$100M goal During the first quarter of 2025, the company recorded $25M in restructuring costs and expects to achieve annual run-rate savings at the high end of its $75M-$100M goal by the end of 2025.
0 · Reply
DonCorleone77
DonCorleone77 May. 5 at 10:31 AM
$HSIC Henry Schein backs FY25 adjusted EPS $4.80-$4.94, consensus $4.84 Backs FY25 revenue growth about 2%-4% over 2024, consensus $13.01B. Sees FY25 adjusted EBITDA growth mid-single digits.
0 · Reply
Latest News on HSIC
Henry Schein Post Earnings Review

May 17, 2025, 9:30 AM EDT - 5 weeks ago

Henry Schein Post Earnings Review


Henry Schein, Inc. (HSIC) Q1 2025 Earnings Call Transcript

May 5, 2025, 4:26 PM EDT - 6 weeks ago

Henry Schein, Inc. (HSIC) Q1 2025 Earnings Call Transcript


Henry Schein Reports First Quarter 2025 Financial Results

May 5, 2025, 6:00 AM EDT - 6 weeks ago

Henry Schein Reports First Quarter 2025 Financial Results


Henry Schein Looks Bullish (Technical Analysis)

Mar 11, 2025, 4:25 AM EDT - 3 months ago

Henry Schein Looks Bullish (Technical Analysis)


Henry Schein, Inc. (HSIC) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 4:09 PM EST - 4 months ago

Henry Schein, Inc. (HSIC) Q4 2024 Earnings Call Transcript


Japan In The Spotlight; Blockchain In AI's Shadow

Jan 31, 2025, 10:30 PM EST - 5 months ago

Japan In The Spotlight; Blockchain In AI's Shadow

APO BBJP DBJP DFJ DXJ DXJS EWJ


Henry Schein Completes Acquisition of Acentus

Jan 15, 2025, 6:30 AM EST - 5 months ago

Henry Schein Completes Acquisition of Acentus


Henry Schein to Participate in Investor Conferences in December

Nov 21, 2024, 6:30 AM EST - 7 months ago

Henry Schein to Participate in Investor Conferences in December


Henry Schein, Inc. (HSIC) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 9:35 PM EST - 8 months ago

Henry Schein, Inc. (HSIC) Q3 2024 Earnings Call Transcript


Henry Schein beats quarterly profit estimates on lower costs

Nov 5, 2024, 7:59 AM EST - 8 months ago

Henry Schein beats quarterly profit estimates on lower costs


Henry Schein to Participate in Investor Conferences in November

Oct 24, 2024, 6:30 AM EDT - 8 months ago

Henry Schein to Participate in Investor Conferences in November


swingingtech
swingingtech Jun. 4 at 9:53 PM
$CIEN $HSIC $RNA https://wallstreetwaves.com/key-wednesday-options-activity-cien-hsic-rna/
0 · Reply
OptionRunners
OptionRunners Jun. 4 at 6:27 PM
$HSIC Seller of the July 18th $75/$80 call spreads 5,000 times for $0.86. Looks to be closing those out for a loss.
0 · Reply
ZacksResearch
ZacksResearch May. 26 at 1:22 PM
Henry Schein ($HSIC) — is the stock a hidden gem or stuck in the mud? 🤔 📊 Henry Schein One's software is driving robust gains amid macroeconomic challenges, with nearly 20% YoY growth in Dentrix Ascend and Dentally subscriptions. 📉 Yet, global macro pressures and fierce competition could weigh on results, although the recent dip in gross profit was due to an increase in cost of sales. Deep dive here 👉 https://www.zacks.com/commentary/2477016/should-you-retain-henry-schein-stock-in-your-portfolio-right-now?cid=sm-stocktwits-2-2477016-body&ADID=SYND_STOCKTWITS_TWEET_2_2477016_BODY
0 · Reply
ZacksResearch
ZacksResearch May. 26 at 12:04 PM
Investors are optimistic about $HSIC, owing to the strong performance of its Henry Schein One business. Explore further: https://www.zacks.com/stock/news/2477016/should-you-retain-henry-schein-stock-in-your-portfolio-right-now?cid=sm-stocktwits-2-2477016-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2477016_TEASER
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine May. 16 at 8:08 PM
$HSIC closes $250M strategic investment from KKR - now holding 12% of shares. KKR's Dan Daniel joins board as independent director. Cash infusion helps debt concerns, but dilution at $76.10/share raises eyebrows. Market will decide if KKR's operational expertise justifies the equity cost. https://www.sec.gov/Archives/edgar/data/1000228/000119312525121679/d919434d8k.htm
0 · Reply
OptionRunners
OptionRunners May. 12 at 7:16 PM
$HSIC Buyer of the July 18th $75/$80 call spreads 5,000 times for $1.00
0 · Reply
JarvisFlow
JarvisFlow May. 6 at 1:29 PM
Wells Fargo has adjusted their stance on Henry Schein ( $HSIC ), setting the rating to Equal-Weight with a target price of 80 → 75.
0 · Reply
JarvisFlow
JarvisFlow May. 6 at 12:30 PM
Barrington Research updates rating for Henry Schein ( $HSIC ) to Outperform, target set at 90 → 86.
0 · Reply
DonCorleone77
DonCorleone77 May. 5 at 10:32 AM
$HSIC Henry Schein sees annual run-rate savings at high end of $75M-$100M goal During the first quarter of 2025, the company recorded $25M in restructuring costs and expects to achieve annual run-rate savings at the high end of its $75M-$100M goal by the end of 2025.
0 · Reply
DonCorleone77
DonCorleone77 May. 5 at 10:31 AM
$HSIC Henry Schein backs FY25 adjusted EPS $4.80-$4.94, consensus $4.84 Backs FY25 revenue growth about 2%-4% over 2024, consensus $13.01B. Sees FY25 adjusted EBITDA growth mid-single digits.
0 · Reply
DonCorleone77
DonCorleone77 May. 5 at 10:30 AM
$HSIC Henry Schein reports Q1 adjusted EPS $1.15, consensus $1.11 Reports Q1 revenue $3.17B, consensus $3.23B. "We are pleased with our first quarter financial results as well as the momentum we are seeing heading into the second quarter and remain confident in the fundamentals of our business," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. "We are advancing our BOLD+1 Strategic Plan, which has been refreshed for 2025 to 2027, with our team focused on growing the distribution business through increasing operational efficiency and enhancing customer experience, growing our dental and medical specialty businesses and corporate brand products, and further developing our digital footprint and digital solutions. We remain committed to our long-term financial goal of high-single-digit to low-double-digit earnings growth by continuing to successfully execute against this strategy," Mr. Bergman added.
0 · Reply
trading_momentum
trading_momentum May. 5 at 3:59 AM
$TSN $ON $CMI $ZBH $HSIC Notable ERs premarket Monday
0 · Reply
ChessGM
ChessGM May. 2 at 1:42 AM
$HSIC Heads up alert! Upcoming earnings on Monday, 5/5/2025 for $HSIC Bearish (2.5) In recent evaluations of Henry Schein, Inc. (HSIC), several key financial metrics paint a mixed picture. The company's trailing P/E ratio currently stands at approximately 22.5, which indicates that the stock is moderately valued compared to its industry average of 20. The earnings per share (EPS) growth has been relatively stagnant, with recent reports suggesting a decrease in stock price by 8.4% over the past month, leading to concerns about investor confidence. Analysts project a revenue growth rate of around 5% for the upcoming quarter, predominantly driven by recovery in its dental and medical segments. However, the stock's performance has been inconsistent, particularly in light of a recent cyber incident that impacted operations. Comparatively, HSIC's peers have shown more robust performance metrics, which could contribute to an ongoing struggle for market share in the competitive healthcare solutions sector. Looking ahead to the upcoming earnings report scheduled for May 5, 2025, expectations are cautiously optimistic. Analysts anticipate that Henry Schein will demonstrate an ability to rebound from its recent challenges, with consensus estimates suggesting earnings growth of approximately 8% year-over-year. Historical performance indicates that Henry Schein has generally exceeded analyst expectations in prior quarters, which could lend credibility to these forecasts. Nevertheless, the potential impact of the company's mixed financials and recent stock price decline could temper enthusiasm among investors. This upcoming report will be crucial in assessing whether the company can navigate its current headwinds and regain momentum. - Funds were net buyers of $HSIC during the previous reporting quarter. - Top 5 funds with large holdings in $HSIC: * Generation Investment Management LLP $190MM. CGMFundRank: 59%, Fund Website: www.generationim.com * Palestra Capita $183MM. New position. CGMFundRank: 80% * Southpoint Capital Advisors LP $180MM. CGMFundRank: 74%, Fund Website: www.southpointcapital.com * Steadfast Capital Management LP $113MM. CGMFundRank: 90%, Fund Website: www.steadfast.com * Adage Capital P $34MM. CGMFundRank: 73%, Fund Website: www.adagecapital.com - Last 10 days performance: 3% - Last 30 days performance: -6% - Last 90 days performance: -19% Follow ChessGM on stocktwits.com to get timely earnings alerts. Not a financial advice. Not a trading signal.
0 · Reply
ZacksResearch
ZacksResearch Apr. 28 at 3:17 PM
$HSIC is set to report Q1 2025 results on May 5, with Zacks consensus estimates showing revenues at $3.23B (up 1.8% YoY) and EPS at $1.11 (up 0.9% YoY). Recent acquisitions and steady dental sales may drive positive results despite challenges in medical distribution. 📈 https://www.zacks.com/commentary/2456956/hsic-gears-up-for-q1-earnings-heres-what-you-need-to-know?cid=sm-stocktwits-2-2456956-body&ADID=SYND_STOCKTWITS_TWEET_2_2456956_BODY
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Apr. 13 at 8:24 AM
$HSIC at $64 with below-average volume, while $ISRG trading at $494 with 78% above-average volume. ISRG showing 670% outperformance vs HSIC. MedicalTech sector heating up, but which one will lead the charge?
0 · Reply
DonCorleone77
DonCorleone77 Apr. 7 at 11:19 AM
$HSIC Henry Schein receives validation of net-zero science-based targets Henry Schein announced that the Science Based Targets initiative has approved the company's near-term and long-term science-based emissions reduction targets and has verified Henry Schein's net-zero science-based target by 2050.
0 · Reply
Estimize
Estimize Mar. 19 at 1:15 PM
Wall St is expecting 1.13 EPS for $HSIC Q1 [Reporting 05/13 BMO] http://www.estimize.com/intro/hsic?chart=historical&metric_name=eps&utm_co
0 · Reply
swingingtech
swingingtech Mar. 4 at 5:50 AM
$HSIC https://wallstreetwaves.com/notable-hsic-options-strategies-for-january-2026-puts-and-calls-to-watch/
0 · Reply
JarvisFlow
JarvisFlow Feb. 26 at 6:35 PM
UBS updates rating for Henry Schein ($HSIC) to Neutral, target set at 83 → 80.
0 · Reply
JarvisFlow
JarvisFlow Feb. 26 at 1:10 PM
Barrington Research has updated their rating for Henry Schein ($HSIC) to Outperform with a price target of 90.
0 · Reply
Estimize
Estimize Feb. 25 at 11:06 PM
$HSIC reported 1.19 EPS and 3,191 revenue for Q4. http://www.estimize.com/intro/hsic?chart=historical&metric_name=eps&utm_content=HSIC&utm_
0 · Reply
d_risk
d_risk Feb. 25 at 8:35 PM
$HSIC - Henry Schein Inc. Common Stock - 10K - Updated Risk Factors HSIC faces new risks from strategic growth challenges, a new partnership, activist investors, and global cost containment pressures, while stricter EU MDR and evolving regulations on AI, cybersecurity, and data protection heighten compliance risks and costs. #Risk https://d-risk.ai/HSIC/10-K/2025-02-25
0 · Reply